Drugs / WenXin keli
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT02319603 Comparator | Jan 2015 → Feb 2017 | cardiac rhythm disease | Beijing Bozhiyin T&S Co., Ltd. | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | WenXin keli | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02319603 ↗ |
| Route | Oral | “Oral ,1 bag each time, 3 times a day, 4 weeks for 1 course of treatment.” NCT02319603 ↗ |